Cartel claim against Uber goes to India’s Supreme Court

India’s top court will hear the merits of a case against Uber and Ola alleging that they operate an anticompetitive pricing model.

CMA backtracks on JD Sports fine

The UK’s antitrust watchdog has revoked the £300,000 fine it imposed on JD Sports for breaching an interim order after new information came to light during the retailer’s appeal against the penalty.

Czech court restores gun-jumping fine

Czech Republic's highest administrative court has reinstated the national competition authority’s gun-jumping fine against fuel company Armex Oil after a lower court had reduced the sanction for being disproportionate.

GCR USA Tipline
GCR Asia Tipline
Germany's Facebook ruling – A treasure trove of novel issues

On 23 June 2020, Germany’s Federal Court of Justice upheld the immediate enforcement of an order by the Federal Cartel Office against Facebook, prohibiting the company from collecting user data from other …

Exclusive: An interview with John Penrose

The UK government announced on 14 September that John Penrose MP will lead a review of the country’s competition policy, as it prepares to leave the European Union and tackle the economic …

Tackling market distortions from foreign subsidies

In June, the European Commission released a white paper seeking views on three proposed new tools to give it greater control over the acquisitions and activities of foreign-subsidised companies within the bloc. …

Owing to coronavirus, CCI adopts “lenient” approach in admitted cartel cases

Competition authorities around the world have adopted measures to help businesses collaborate throughout the covid-19 pandemic, although they have warned against taking advantage of the health crisis. Khaitan & Co partner Sagardeep …

Pharma & Healthcare: Q2 2020

    Overpriced but underenforced? • Healthcare on life support • Delay no more? • A little smoke, but no fire • A Q&A with KFTC chair Joh Sung-wook • Korea’s competition bar • GCR Live Pharmaceuticals • Market definition in pharmaceutical markets

Pharma & Healthcare: Q2 2020


From the publisher of:

Get unlimited access to all Global Competition Review content